UK +44 (0)1865 849841
Malaysia +60 3 2117 5193
  • Biocontrol & Biostimulants: The Brightest Spots in Agriculture

    Over the next few years, the biocontrol and biostimulants market is expected to grow at over 10% per year. Current estimates show that the global biostimulant market is at $2 billion.

  • Monogenic Autoimmune Disorders Display Gut Microbial Dysbiosis

    Yuying Liu, Associate Professor in the Department of Pediatrics at the University of Texas, discusses her work reprogramming gut microbial dysbiosis due to Foxp3 Treg deficiency with probiotics.

  • Precision Medicine: The Solution to the Largest Inefficiency in Healthcare Systems

    Rheumatoid arthritis is one of the highest sources of the inefficiency of worldwide health care systems. This could be avoided by more tailored and individualised therapeutic strategies.

  • Using 3D Imaging to Enable New Discoveries in Medicine

    The three-dimensional reconstruction and examination of tissue at microscopic resolution have significant potential to enhance the study of normal and disease processes.

  • The Big List of Synthetic Biology Companies and Investors

    We’ve compiled a list of 146 synthetic biology companies, investors and dates active. Whether you’re just curious or are looking for an investor from seed to series, you’re sure to find something useful.

What’s Driving Change in Drug Discovery and Development?

The past decade has witnessed huge advances in both scientific research and technological innovations within the drug discovery market. Here Dr James Willans, Chief Technology Officer of the not-for-profit organisation and educational charity, Lhasa Limited, discusses two significant areas that have the potential to further transform the industry over the coming years.

Read More

Understanding the Molecular Basis of Disease Resistance in Plants

There has been tremendous progress in understanding the molecular basis of disease resistance in plants in the last twenty years. However, translation of this knowledge into practical use has been slow.

Read More

Engineering the Microbiome – the Next Frontier

Microbial ecology, our understanding of what determines the robustness and community dynamics of microbial consortia, and synthetic biology, the art of engineering microorganisms to perform particular physiological or metabolic functions, are rapidly becoming allies in the race to develop novel therapeutic strategies in the microbiome space.

Read More

Process Control for Immunohistochemistry Staining Procedures

An extensively used technique for evaluating the expression of tissue antigens and their behaviour is known as immunohistochemistry (IHC). In this technique, the primary antibody raised against the specific antigen and a secondary antibody against the primary one is used for detecting specific targets of clinical relevance. IHC has the greatest impact on diagnostic pathology compared to any other technique. Although modern methods of flow cytometry and molecular diagnosis have also contributed enormously, IHC still remains the most relevant solution for various pathological diagnostic problems.

Read More

Presentation Slide Release: Biologics Discovery and Development

Presented at the 3rd Biologics and Biosimilars Congress, these 3 sets of slides are available to download and share with your colleagues.

Read More

Synthetic Biology Research and Applications: An Open Letter From John Glass

Dear colleagues,

Since the minimal cell idea was proposed by Max Delbruck and his Phage School colleagues in the 1930s, biologists have sought to build a cell that encodes only the minimum set of genes necessary for life. Such a minimal cell could be used to investigate the first principles of cellular life.

Read More

The Big List of Prebiotics/Probiotics Companies and Investors

Interest in microbiota has reached all areas of human health and disease. As a result, the therapeutic potential of probiotics has expanded. 2013 saw a surge of investment into prebiotics and probiotics, coinciding with an increase in microbiome funding. In the last decade, investment has quadrupled. 

Read More

Phytobiomes: Embracing Complexity to Achieve a New Vision for Agriculture

Imagine a world in which farmers have at their disposal analytical tools that help them determine the crop, management practices, and inputs to apply to a specific field in a given year, taking into consideration all physical (climate, soil…) and biological conditions (microbes, pests, disease, weeds, animals…)

Read More

What’s Driving Change in Drug Discovery and Development?

The past decade has witnessed huge advances in both scientific research and technological innovations within the drug discovery market. Here Dr James Willans, Chief Technology Officer of the not-for-profit organisation and educational charity, Lhasa Limited, discusses two significant areas that have the potential to further transform the industry over the coming years.

Read More

Engineering the Microbiome – the Next Frontier

Microbial ecology, our understanding of what determines the robustness and community dynamics of microbial consortia, and synthetic biology, the art of engineering microorganisms to perform particular physiological or metabolic functions, are rapidly becoming allies in the race to develop novel therapeutic strategies in the microbiome space.

Read More

Process Control for Immunohistochemistry Staining Procedures

An extensively used technique for evaluating the expression of tissue antigens and their behaviour is known as immunohistochemistry (IHC). In this technique, the primary antibody raised against the specific antigen and a secondary antibody against the primary one is used for detecting specific targets of clinical relevance. IHC has the greatest impact on diagnostic pathology compared to any other technique. Although modern methods of flow cytometry and molecular diagnosis have also contributed enormously, IHC still remains the most relevant solution for various pathological diagnostic problems.

Read More

Presentation Slide Release: Biologics Discovery and Development

Presented at the 3rd Biologics and Biosimilars Congress, these 3 sets of slides are available to download and share with your colleagues.

Read More

Synthetic Biology Research and Applications: An Open Letter From John Glass

Dear colleagues,

Since the minimal cell idea was proposed by Max Delbruck and his Phage School colleagues in the 1930s, biologists have sought to build a cell that encodes only the minimum set of genes necessary for life. Such a minimal cell could be used to investigate the first principles of cellular life.

Read More

The Big List of Prebiotics/Probiotics Companies and Investors

Interest in microbiota has reached all areas of human health and disease. As a result, the therapeutic potential of probiotics has expanded. 2013 saw a surge of investment into prebiotics and probiotics, coinciding with an increase in microbiome funding. In the last decade, investment has quadrupled. 

Read More

The Droplet Biopsy Chip: Towards Capturing Rare Circulating Tumour Cells

In 1869, Thomas Ashworth first observed circulating tumour cells (CTC) in the blood of a man with metastatic cancer using an optical microscope. He postulated that “cells identical with those of cancer itself being seen in the blood may tend to throw some light upon the mode of origin of multiple tumours existing in the same person1.

Read More

Are you looking for a faster horse in drug discovery?

Discovering and developing new drugs is difficult. Very difficult indeed. The cost of developing a new medicine, when you factor in the costs of all those projects which fail before getting to market, is increasing and is Very Large Indeed so what can be done to get us out of this situation?

Read More

Understanding the Molecular Basis of Disease Resistance in Plants

There has been tremendous progress in understanding the molecular basis of disease resistance in plants in the last twenty years. However, translation of this knowledge into practical use has been slow.

Read More

Phytobiomes: Embracing Complexity to Achieve a New Vision for Agriculture

Imagine a world in which farmers have at their disposal analytical tools that help them determine the crop, management practices, and inputs to apply to a specific field in a given year, taking into consideration all physical (climate, soil…) and biological conditions (microbes, pests, disease, weeds, animals…)

Read More

Biocontrol & Biostimulants: The Brightest Spots In Agriculture

Biocontrol and biostimulants hold the key to important agricultural benefits such as improved efficiency, increased yield and greater sustainability. 

Read More

Novel Applications Of The Chloroplast Genome

Henry Daniell’s research analyses the crop chloroplast genome. In the past years, more than 40 crop chloroplasts genome were sequenced in his lab, including some of the most important crops such as coffee, orange, cotton and soybean.

Read More

Probiotic Consortia Applications In Non-Sterile Soil

Plants feed microbial communities that, in return, provide the plant with growth hormones and antibiotics. Alexandre Jousset’s research focuses on probiotics consortia in tomato plant roots that form a shield defending plant tissues from Ralstonia solanacearum (Wei et al., 2015). This is an aerobic non-spore forming plant pathogenic bacterium colonising the xylem and causing bacterial wilt in its host. It can affect most world crop species including tomato, potato, banana and tobacco and there’s still no cure for this disease (Hu et al., 2016).

Read More

The Wheat Genome Sequence Odyssey

As the world population is expected to reach 9.8 billion by 2050, it is crucial to have innovative genomics tools to address global food security in a sustainable way.

Read More

Biofuels; The Energy Resource Of Our Future

Norman Lewis’ research currently focuses on the composition of phenylpropanoid metabolism pathway, which provides plants with neolignans and lignans. These are organic compounds giving structure and rigidity to the cell wall and allowing the normal growth and developments of plants. We interviewed him about his research.

Read More

The Synergistic Relationship Between University and Industry: A Case Study

All companies look to universities for the training and expertise of their future workforce. Yet, many companies have discovered that relationships with universities can yield much more than access to future staff members.

Read More

Network-Driven Drug Discovery – Circumventing the Limitations of Target-Driven Discovery

Over the past five years, e-Therapeutics have created a drug discovery engine based on a combination of large-scale, proprietary databases and a suite of computational tools. Small molecules are evaluated by their potential bioactivity in the search for better and more effective drugs to address unmet medical needs. This article outlines the core principles and advantages of the Network-Driven Drug Discovery (NDD) approach.

Read More

Next Generation Sequencing Technology: An Open Letter From Mostafa Ronaghi

Dear Colleagues,

Launched in 1990, the Human Genome Project involved thousands of scientists across the globe and took 13 years to complete. Using capillary electrophoresis-based Sanger sequencing, it cost nearly $3 billion. In 2014 Illumina announced the first technology that could sequence a whole genome for less than $1,000.

Read More

Challenges in Printing Hybrid Light Emitting Diodes

Organic Light Emitting Diodes (OLEDs)

Organic Light Emitting Diodes (OLEDs) are sub-micrometric devices formed by multi-stacked materials that have reached the appropriate Technological Readiness Level to be present in displays. Intense research has permitted the construction of diodes with long lifetimes, multi-colour emission and size variety.

Read More

Enabling Flexible Displays and Sensors With Organic Electronics

While most conventional electronics are based on silicon transistors, there are other approaches being developed that seek to enable truly flexible components. At FlexEnable we believe the only way you can make truly flexible electronics is to start with truly flexible materials, so we use plastics (also referred to as organic materials) instead of ceramics to make our transistors.

Read More

E-waste Recycling and Repurposing

Electronic waste (e-waste) is a fast growing problem. The UN estimates between 20-50 million tons of electronic waste is discarded every year, with only 12.5% of this being recycled. This leaves a colossal amount of e-waste sitting in landfill or improperly disposed of, which in turn leads to toxic materials leaching into the soil and water supply.

Read More

Printed and Flexible Electronics: An Open Letter From Ton van Mol

Here at the Holst Centre, our technologies have matured in the last few years and our focus has expanded. We concentrate on application driven research, such as wearable health, automotive, the Internet of Things and solar energy.

Read More

From Liquid Crystal Displays in 1996 to Microfluidics in 2016

Emmanuel Delamarche is a researcher at IBM Research who presented at our 2nd Microfluidics Congress about his research on precision diagnostics based on modular capillary-driven elements.

Read More

Subscribe to Our Newsletter

Get free reports and resources from our world class speakers.
  • This field is for validation purposes and should be left unchanged.

Life Sciences Twitter Feed

Archive